TXN and prostate cancer: We summarize evidence from multiple malignancies, including breast, colon, lung, prostate cancer, and B-cell chronic lymphocytic leukemia, showing that altered exofacial thiol-disulfide states driven by TXN1 and PDI overexpression represent reproducible biochemical features of cancer progression.